We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

88 hedge funds and large institutions have $363M invested in Collegium Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

463% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 8

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

81.46% more ownership

Funds ownership: 0% → 81.46% (+81%)

24% more funds holding

Funds holding: 71 → 88 (+17)

19% more capital invested

Capital invested by funds: $305M → $363M (+$58M)

69% less call options, than puts

Call options by funds: $238K | Put options by funds: $779K

Holders
88
Holders Change
+17
Holders Change %
+23.94%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
45
Reduced
8
Closed
3
Calls
$238K
Puts
$779K
Net Calls
-$541K
Net Calls Change
+$364K

Top Buyers

1
SAM
Sectoral Asset Management
Quebec, Canada
+$23.2M
2
PHS
PFM Health Sciences
California
+$16.9M
3
Franklin Resources
Franklin Resources
California
+$14.8M
4
EAM
EverPoint Asset Management
Connecticut
+$7.64M
5
CCM
Cadian Capital Management
New York
+$7.29M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$995K
2
PP
PDT Partners
New York
-$458K
3
Deutsche Bank
Deutsche Bank
Germany
-$299K
4
TC
TFS Capital
Pennsylvania
-$188K
5
TG
TLP Group
Illinois
-$164K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
76
Catamount Wealth Management
Connecticut
$18K – – –
CG
77
Cutler Group
California
$18K +$19.9K +1,200 New
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$13.5K -$764 -46 -5%
BlackRock
79
BlackRock
New York
$9K – – –
JIC
80
Joel Isaacson & Co
New York
$9K – – –
MAM
81
Meeder Asset Management
Ohio
$7K +$7.45K +448 New
MFS
82
MSI Financial Services
Massachusetts
$3K – – –
NFG
83
Next Financial Group
Texas
$3K – – –
GAM
84
Gemmer Asset Management
California
$2K – – –
KKAMG
85
Kernodle & Katon Asset Management Group
Arkansas
$2K – – –
KF
86
Krilogy Financial
Missouri
$2K +$1.66K +100 New
Envestnet Asset Management
87
Envestnet Asset Management
Illinois
$1K +$1.16K +70 New
TRCT
88
Tower Research Capital (TRC)
New York
$1K +$1.58K +95 New
PP
89
PDT Partners
New York
– -$458K -23,800 Closed
TG
90
TLP Group
Illinois
– -$164K -8,500 Closed
SO
91
STRS Ohio
Ohio
– -$38K -2,000 Closed
1 2 3
4

COLL Hedge Fund Activity: Q4 2016 in Review

88 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2016, worth a combined $363M — up 19% from $305M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new COLL positions and 3 closed out — a net gain of 17 holders — while 45 added to existing stakes and 8 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $23.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $995K.

  • 88 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2016, up from 71 in Q3 2016.
  • Funds reported $363M of Collegium Pharmaceutical stock for Q4 2016, up 19% quarter-over-quarter.
  • 20 funds opened new Collegium Pharmaceutical positions in Q4 2016 and 3 closed out, a net change of +17 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2016 was Sectoral Asset Management, an estimated $23.2M added.
  • The largest Collegium Pharmaceutical seller in Q4 2016 was Massachusetts Financial Services, an estimated $995K sold.

Based on aggregated 13F filings for Q4 2016.